Tags

Type your tag names separated by a space and hit enter

Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
Vaccine. 2012 Jul 13; 30(33):5038-58.V

Links

  • PMC Free PDF
    • Publisher Full Text
    ncbi.nlm.nih.gov
    linkinghub.elsevier.com
    Aggregator Full Text

    Authors+Show Affiliations

    Gershman MD
    Division of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, N.E., MS-E03, Atlanta, GA 30333, USA. contact@brightoncollaboration.org
    Staples JE
    No affiliation info available
    Bentsi-Enchill AD
    No affiliation info available
    Breugelmans JG
    No affiliation info available
    Brito GS
    No affiliation info available
    Camacho LA
    No affiliation info available
    Cottin P
    No affiliation info available
    Domingo C
    No affiliation info available
    Durbin A
    No affiliation info available
    Gascon J
    No affiliation info available
    Guenaneche F
    No affiliation info available
    Hayes EB
    No affiliation info available
    Jelenik Z
    No affiliation info available
    Khromava A
    No affiliation info available
    Martins Rde M
    No affiliation info available
    Wilson MM
    No affiliation info available
    Massy N
    No affiliation info available
    Nasidi A
    No affiliation info available
    Niedrig M
    No affiliation info available
    Sherwat A
    No affiliation info available
    Tsai T
    No affiliation info available
    Vilella A
    No affiliation info available
    Wilson ME
    No affiliation info available
    Kohl KS
    No affiliation info available
    Brighton Collaboration Viscerotropic Disease Working Group
    No affiliation info available

    MeSH

    Adverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsHumansVaccination

    Pub Type(s)

    Journal Article

    Language

    eng

    PubMed ID

    22561144

    Citation

    Gershman, Mark D., et al. "Viscerotropic Disease: Case Definition and Guidelines for Collection, Analysis, and Presentation of Immunization Safety Data." Vaccine, vol. 30, no. 33, 2012, pp. 5038-58.
    Gershman MD, Staples JE, Bentsi-Enchill AD, et al. Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2012;30(33):5038-58.
    Gershman, M. D., Staples, J. E., Bentsi-Enchill, A. D., Breugelmans, J. G., Brito, G. S., Camacho, L. A., Cottin, P., Domingo, C., Durbin, A., Gascon, J., Guenaneche, F., Hayes, E. B., Jelenik, Z., Khromava, A., Martins, R. d. e. . M., Wilson, M. M., Massy, N., Nasidi, A., Niedrig, M., ... Kohl, K. S. (2012). Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine, 30(33), 5038-58. https://doi.org/10.1016/j.vaccine.2012.04.067
    Gershman MD, et al. Viscerotropic Disease: Case Definition and Guidelines for Collection, Analysis, and Presentation of Immunization Safety Data. Vaccine. 2012 Jul 13;30(33):5038-58. PubMed PMID: 22561144.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data. AU - Gershman,Mark D, AU - Staples,J Erin, AU - Bentsi-Enchill,Adwoa D, AU - Breugelmans,J Gabrielle, AU - Brito,Glacus S, AU - Camacho,Luiz Antonio Bastos, AU - Cottin,Pascale, AU - Domingo,Cristina, AU - Durbin,Anna, AU - Gascon,Joaquim, AU - Guenaneche,Fouzia, AU - Hayes,Edward B, AU - Jelenik,Zsuzsanna, AU - Khromava,Alena, AU - Martins,Reinaldo de Menezes, AU - Wilson,Mario Masana, AU - Massy,Nathalie, AU - Nasidi,Abdulsalami, AU - Niedrig,Matthias, AU - Sherwat,Adam, AU - Tsai,Theodore, AU - Vilella,Anna, AU - Wilson,Mary Elizabeth, AU - Kohl,Katrin S, AU - ,, Y1 - 2012/05/04/ PY - 2012/04/13/received PY - 2012/04/19/accepted PY - 2012/5/8/entrez PY - 2012/5/9/pubmed PY - 2012/10/18/medline SP - 5038 EP - 58 JF - Vaccine JO - Vaccine VL - 30 IS - 33 SN - 1873-2518 UR - https://www.unboundmedicine.com/medline/citation/22561144/full_citation L2 - https://linkinghub.elsevier.com/retrieve/pii/S0264-410X(12)00613-5 DB - PRIME DP - Unbound Medicine ER -